SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-06-056304
Filing Date
2006-08-21
Accepted
2006-08-21 17:08:21
Documents
4
Period of Report
2006-08-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES a06-18423_18k.htm 8-K 32936
2 EX-99 a06-18423_1ex99d1.htm EX-99.1 20703
3 GRAPHIC g184231mmi001.jpg GRAPHIC 3470
4 GRAPHIC g184231mmi002.jpg GRAPHIC 2286
  Complete submission text file 0001104659-06-056304.txt   63720
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32715 | Film No.: 061046876
SIC: 2835 In Vitro & In Vivo Diagnostic Substances